Literature DB >> 3169632

Prolactin levels in blood from the intervillous space of the human placenta.

R A Ferriani1, M F Silva de Sá.   

Abstract

The secretory products of the human placenta are released in the intervillous space (IS), which also represents the main site of maternal-fetal exchange. This compartment, however, has not been studied in terms of prolactin (PRL) metabolism during gestation. In the present study we determined PRL levels in maternal peripheral (MP) blood, in blood from the IS and in blood from the umbilical artery (UA) and vein (UV) of 24 clinically normal parturients and their concepti. PRL levels in MP plasma (means = 111.7 +/- 5.5 ng/ml) did not differ significantly (p greater than 0.05) from those in IS plasma (means = 131.6 +/- 64.3 ng/ml). PRL levels in UA plasma (means = 206.2 +/- 67.5 ng/ml) also showed no significant difference (p greater than 0.05) from those in UV plasma (means = 243.8 +/- 86.1 ng/ml) but both were significantly higher than MP and IS plasma levels (p less than 0.01). These data permit us to conclude that the placenta may not be the source of PRL circulating in maternal peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169632     DOI: 10.1159/000293676

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  1 in total

1.  Prolactin decreases LPS-induced inflammatory cytokines by inhibiting TLR-4/NFκB signaling in the human placenta.

Authors:  A Olmos-Ortiz; M Déciga-García; E Preciado-Martínez; L Bermejo-Martínez; P Flores-Espinosa; I Mancilla-Herrera; C Irles; A C Helguera-Repetto; B Quesada-Reyna; V Goffin; L Díaz; V Zaga-Clavellina
Journal:  Mol Hum Reprod       Date:  2019-10-28       Impact factor: 4.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.